Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Arch Venture Fund Vii Lp


  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2019-07-17
  • Large Shareholder at Twist Bioscience Corp (TWST), 2018-11-06
  • Large Shareholder at Unity Biotechnology Inc. (UBX), 2018-05-07
  • Other at Pulmatrix Inc. (PULM), 2018-04-12
  • Large Shareholder at Phaserx Inc. (PZRX), 2016-05-25
  • Large Shareholder at Juno Therapeutics Inc. (JUNO), 2016-03-18
  • Large Shareholder at Juno Lighting Inc (JUNO), 2016-03-18
  • Large Shareholder at Sage Therapeutics Inc. (SAGE), 2015-06-22
  • Large Shareholder at Agios Pharmaceuticals Inc (AGIO), 2015-02-23
  • Large Shareholder at Receptos Inc. (RCPT), 2014-05-15
  • Large Shareholder at Bluebird Bio Inc. (BLUE), 2013-06-26
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SYRS $12.50 400,000 Large Shareholder 4,637,137 2016-07-06 Filing
RCPT $14.00 284,485 Large Shareholder 2,101,376 2013-05-14 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SYRS $7.70 34,521 Large Shareholder 4,242,051 2019-07-17 Filing
SYRS $7.81 25,779 Large Shareholder 4,276,572 2019-07-16 Filing
SYRS $8.27 2,700 Large Shareholder 4,302,051 2019-07-15 Filing
SYRS $8.15 43,000 Large Shareholder 4,305,051 2019-03-14 Filing
SYRS $8.20 2,820 Large Shareholder 4,348,051 2019-03-13 Filing